Endocannabinoids and polyunsaturated fatty acids in early schizophrenia: Changes under antipsychotics and association with the response to treatment
{{output}}
Evidence supports polyunsaturated fatty acid (PUFA) and endocannabinoid (eCB) metabolism dysregulation in schizophrenia. However, data on the topic are inconsistent, and the precise role of these mediators remains unclear. The study aimed to analyze free plasm... ...
